- Research article
- Open Access
Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS
Molecular Neurodegeneration volume 7, Article number: 10 (2012)
Amyotrophic lateral sclerosis (ALS) is progressive neurodegenerative disease characterized by the loss of motor function. Several ALS genes have been identified as their mutations can lead to familial ALS, including the recently reported RNA-binding protein fused in sarcoma (Fus). However, it is not clear how mutations of Fus lead to motor neuron degeneration in ALS. In this study, we present a Drosophila model to examine the toxicity of Fus, its Drosophila orthologue Cabeza (Caz), and the ALS-related Fus mutants.
Our results show that the expression of wild-type Fus/Caz or FusR521G induced progressive toxicity in multiple tissues of the transgenic flies in a dose- and age-dependent manner. The expression of Fus, Caz, or FusR521G in motor neurons significantly impaired the locomotive ability of fly larvae and adults. The presynaptic structures in neuromuscular junctions were disrupted and motor neurons in the ventral nerve cord (VNC) were disorganized and underwent apoptosis. Surprisingly, the interruption of Fus nuclear localization by either deleting its nuclear localization sequence (NLS) or adding a nuclear export signal (NES) blocked Fus toxicity. Moreover, we discovered that the loss of caz in Drosophila led to severe growth defects in the eyes and VNCs, caused locomotive disability and NMJ disruption, but did not induce apoptotic cell death.
These data demonstrate that the overexpression of Fus/Caz causes in vivo toxicity by disrupting neuromuscular junctions (NMJs) and inducing apoptosis in motor neurons. In addition, the nuclear localization of Fus is essential for Fus to induce toxicity. Our findings also suggest that Fus overexpression and gene deletion can cause similar degenerative phenotypes but the underlying mechanisms are likely different.
Amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease) is a motor neuron disease that causes a disabling condition whereby the degeneration of motor neurons causes progressive muscle weakness and leads to death usually within five years of disease onset . Most cases of ALS occur sporadically, however a small percentage of cases are inherited. Several ALS genes have been identified, and mutations within them can lead to familial ALS , including Cu/Zn superoxide dismutase (SOD1) , TDP-43  and Fused in sarcoma (Fus) [5–8]. In addition to familial ALS, Fus mutations are also implicated in sporadic ALS cases [9–11]. Both Fus and TDP-43 are DNA- and RNA-binding proteins. While TDP-43 has been intensively studied, the role of Fus in the ALS etiology is largely unknown.
Fus is a ubiquitous multi-domain RNA-binding protein  involved in many processes of RNA metabolism including transcriptional regulation, mRNA splicing and mRNA shuttling between the nucleus and the cytoplasm [13, 14]. In neurons, Fus is also implicated in the transportation of mRNA for local translation in dendrites [15, 16]. Fus mainly localizes in the nucleus, but has also been shown to present at lower levels in the cytoplasm of most cell types, including neurons and glial cells [17, 18]. The ALS-related mutations are clustered in the carboxyl-terminus of Fus and exhibit an abnormal nucleo-cytoplasmic redistribution and cytosolic inclusions in the motor neurons in familial ALS patients [7, 8]. Studies at the cellular level have shown that the nuclear localization sequence (NLS) located in the C-terminus of Fus is necessary and sufficient for nuclear targeting of Fus . ALS mutations within the NLS significantly impair the nuclear targeting function of the sequence, leading to the cytoplasmic accumulation of mutant Fus. Mutations in the NLS have also been shown to promote Fus co-localization with stress granules in the cytosol [19–21]. However, it is still unclear how the mutations cause the toxicity. Moreover, wild-type Fus aggregation has also been reported in several ALS cases. Thus, it is important to determine whether the cytoplasmic or nuclear fraction of Fus is critical to cause the toxicity in ALS. The tentative hypothesis in the field is that cytoplasmic mislocalization and inclusions are important during the disease process. However, this remains to be thoroughly tested.
Appropriately constructed animal models are valuable for defining the link between gene mutations and the ALS disease. Well-established genetics, small genome size, minimal genetic redundancy, and ease of handling have made Drosophila an ideal model system to study conserved mechanisms that are involved in human diseases. Studies using Drosophila as a model have shown that mutating TDP-43 causes locomotive defects , whereas overexpressing TDP-43 causes neurotoxicity , most likely through genetic interactions with TER94, which is an ATPase associated with multiple cellular activities . These findings suggest that Drosophila is a powerful animal model for ALS. Studies of transgenic Drosophila lines with the overexpression of Fus have been reported in the past [25–27], but the molecular mechanisms underlying Fus/Caz function in Drosophila remain elusive. The Drosophila homologue of Fus, Cabeza (Caz), is enriched in the brain and central nervous system [28, 29]. However, the functional link between Drosophila Caz and human Fus has not yet been established.
In this study, we generated and characterized transgenic flies expressing wild-type Fus, several ALS-related Fus mutants, and wild-type Caz using different tissue-specific Gal4 lines. We found that toxicity was dependent on the expression level of Fus/Caz in all tissues examined. Flies overexpressing Fus or Caz by the motor neuron-specific Gal4 showed significantly impaired larval crawling and adult fly movement. Defects in the neuromuscular junctions (NMJs) were evident in these flies. In addition, motor neurons in the ventral nerve cord (VNC) of these flies were disorganized and showed elevated apoptosis. More interestingly, C-terminal NLS is essential for Fus toxicity, since both the deletion of the last 32 amino acids in Fus (FusΔ32) and the addition of an NES to wild type full-length Fus (FusNES) dramatically reduced toxicity in vivo. Finally, we analyzed the caz mutant flies and found that the loss of Caz induced phenotypes in Drosophila eyes, VNC neurons, and NMJs. The lack of Caz in motor neurons caused similar NMJ defects and locomotive impairment as the Fus/Caz overexpressing flies, but did not cause apoptosis in motor neuron cell bodies. Thus, the mechanisms underlying the toxicity caused by Caz deletion and Fus/Caz overexpression are likely different. The genetic model we generated shows that Fus/Caz is required for neuronal function in vivo and that elevated levels of Fus/Caz in the nucleus can induce neuronal toxicity. The findings of this study provide insights into the molecular mechanisms of Fus/Caz in motor neuron degeneration and ALS.
The expression of Fus/Caz results in wing defects and decreased viability in Drosophila
Animal models for neurodegenerative diseases often involve overexpression of disease relevant proteins in yeast, Drosophila, C. elegans, and mouse. We generated transgenic flies with the PhiC31 integration system to integrate human Fus or Drosophila homolog Caz cDNA at the 75B1 attP locus in the Drosophila genome to ensure that the proteins were expressed at the same level without positional effects [30, 31]. Using this precise approach, we investigated the pathogenic properties of human Fus and fly Caz in Drosophila. Individual Fus variants were overexpressed in a tissue-specific fashion using (i) a wing-specific MS1096-Gal4, (ii) a ubiquitous act5C-Gal4 in all fly tissues, (iii) an embryonic nervous system specific Elav-Gal4, and (iv) a larval and adult motor neuron-specific D42-Gal4.
We first found that overexpressing Myc-tagged Fus (Myc-Fus) or FusR521G mutant (Myc-FusR521G) using MS1096-Gal4 interrupted wing growth (Figure 1B-C). The ubiquitous overexpression of Fus severely reduced adult viability at 25°C and 19°C (Figure 1G-H). Overexpressing Fus in neurons using Elav-Gal4 and D42-Gal4 also significantly reduced adult viability at 25°C (Figure 1G), but the adult viability improved at 19°C when the Fus overexpression level was lower (Figure 1H). The overexpression of Myc-FusR521C produced similar phenotypes to those caused by overexpressing Myc-FusR521G (data not shown). Surprisingly, we found that expressing Myc-tagged Fus lacking the last 32 amino acids of the NLS (Myc-FusΔ32) gave rise to a wild-type wing (Figure 1D) and nearly 100% adult viability (Figure 1G-H). These data give the first indication that the C-terminal NLS is required for Fus toxicity in vivo.
Caz is the Drosophila homologue of Fus and has been reported to be enriched in the brain and central nervous system [28, 29]. Caz shares a similar domain structure with Fus (Additional file 1: Figure S1) and exhibits 51% identity to Fus in the C-terminal region containing the RNA recognition motif and RGG domains. However, its in vivo function and its possible role in neurodegeneration are unclear. We examined the potential role of Caz in neurodegeneration using overexpression, RNAi knockdown, and knockout approaches in this study. The overexpression of HA-tagged Drosophila Caz (HA-Caz) caused similar phenotypes in the wing (Figure 1E) and even more dramatic decrease in adult viability (Figure 1G-H). The native Caz protein may adopt a more favorable condition in the flies and therefore induce more severe toxicity compared to overexpressed human Fus. These findings suggest that the overexpression of Fus or Caz had similar growth defects in flies. Interestingly, the knockdown of Caz by RNAi affected wing growth (Figure 1F) and reduced adult viability (Figure 1G-H), suggesting that endogenous Caz is involved in Drosophila growth control. This provides initial evidence that Caz deletion can produce toxicity as well, which was thoroughly examined in caz mutant flies later in this study.
Over-expression of Fus/Caz in Drosophila eye induces retinal degeneration
The Drosophila compound eye, which consists of approximately 750 single eye units called ommatidia, has been used as a model for studying human neurodegenerative disorders . We used a GMR-Gal4 driver to express Myc-Fus, FusR521G, FusΔ32, and HA-Caz in Drosophila eyes. We found that the expression of Fus (Figure 2B-C) or Caz (Figure 2H-I) caused severe eye degeneration. The expression of FusR521G induced a phenotype similar to that caused by Fus (Figure 2D-E). We also examined eye structures of the frontal sections using Eosin Phloxine staining. We found that the ommatidia organization was completely lost in fly eyes expressing Fus, FusR521G, or Caz (Figure 2K, L, and 2N, respectively), compared to eyes from control flies that had an intact structure (Figure 2J). In contrast, flies expressing FusΔ32 showed a nearly wild-type eye (Figure 2F-G) and had little, if any, retinal degeneration (Figure 2M).
We noted that expressing two copies of Fus or Caz gave rise to more severe eye phenotypes than expressing one copy (compare Figure 2C and 2I to Figure 2B and 2H, respectively). These observations suggest that the toxicity and phenotypes are clearly dependent on Fus/Caz expression levels in the Drosophila model system, which supports the hypothesis that the deregulated higher expression of Fus can be toxic. We further found that, in a time course experiment of fly eyes, the overexpression of these proteins produced a progressive eye phenotype, with Caz being the most toxic protein in eyes (Figure 2O-R) and suggesting that the retinal degeneration was progressive with aging. Western blot analysis was performed and confirmed that the proteins were expressed at comparable levels (Additional file 1: Figure S2). We also found that Myc-FusR521C had a similar effect as Myc-FusR521G did (not shown). These findings suggest that Fus/Caz induces toxicity in a dose- and age-dependent manner.
We next systematically characterized the in vivo toxicity of various Fus mutations in different tissues using a variety of Gal4 lines. Table S1 summarizes the results of wing, eye, and adult viability results from the above Fus/Caz constructs and two additional mutations. Sequence analysis revealed a highly conserved tyrosine kinase phosphorylation motif (RXXPY) in the C-terminus of Fus/Caz, and mutation of the tyrosine residue in this motif (FusY526F) significantly reduced the in vivo toxicity of Fus (Table S1). A consistent but striking finding in these experiments is that the truncation mutation FusΔ32 lacking the C-terminal NLS was largely non-toxic in all lines we tested. We generated a shorter truncation mutation of Fus lacking the RGG-rich domain in the C-terminus (Fus1-453) and found that it was also non-toxic and thus allowed full adult viability (Table S1, data not shown).
The expression of Fus/Caz in motor neurons causes locomotive impairment
We next characterized the locomotive function of the flies overexpressing Fus, Fus mutants, or Caz. We used another motor neuron-specific OK371-Gal4, which is expressed earlier than D42-Gal4 in the larval stage. When Fus, FusR521G, or Caz was overexpressed through the OK371-Gal4 line, the locomotive ability of third instar larvae was markedly impaired (Figure 3A). The average moving distances also correlated with the protein toxicity presented in Table S1. The Caz larvae moved the shortest distance and the FusΔ32 larvae moved the longest distance in a specific period of time among the flies expressing different forms of Fus/Caz (Figure 3A). A comparable level of protein expression in larval brain extracts was confirmed by Western blot (Figure 3B).
We further examined the locomotion of adult flies expressing Fus, Fus mutants, and Caz. We used the other motor neuron-specific Gal4 line, D42-Gal4, in the adult movement assays because Fus, FusR521G, and Caz expression by OK371-Gal4 caused pupal lethality. We found that the locomotive ability of two-day-old flies was severely impaired by the expression of Fus or FusR521G but not by the expression of FusΔ32 (Figure 3C). Similar results were achieved by analyzing the ten-day-old flies (Figure 3D). In this experiment, the expression of Caz by the D42-Gal4 caused pupal lethality, indicating that Caz induced severe toxicity (Figure 3C-D). We also found that the expression of FusR521C produced a similar phenotype as that of FusR521G (data not shown). Taken together, the locomotive defects caused by Fus or Caz suggest that Fus/Caz is involved in neurodegeneration after larval stage.
Overexpression of Fus/Caz disrupts presynaptic terminals at the neuromuscular junction (NMJ) and causes disorganization of motor neurons in larval ventral nerve cord (VNC)
To gain more insights into the disease etiology, we analyzed the morphology of motor neuronal presynaptic terminals at the NMJ in flies. Third instar larval muscle fillets were dissected and double-labeled with an anti-HRP antibody to visualize the neuronal membrane and an anti-Dlg antibody to mark the subsynaptic reticulum surrounding each bouton. The expression of a membrane GFP (mGFP) by OK371-Gal4 was used to mark the motor neurons and did not have any effect on bouton formation at NMJ (Figure 4A, F and 4I). Morphological abnormalities were found in larvae co-expressing mGFP with either Fus or Caz by OK371-Gal4. As shown in Figure 4, the overexpression of Fus substantially reduced the area (Figure 4B) and the number of both large and small boutons (Figure 4F and 4I). Compared to Fus, expression of Caz had more severe NMJ defects (Figure 4E, F, H, and 4I). Interestingly, overexpression of FusΔ32 induced little, if any, disruption in the presynaptic terminals (Figure 4D, F, and 4I). These findings are consistent with the locomotive deficiency observed in the animals (Figure 3C-D), suggesting that the abnormal NMJs in flies expressing Fus are responsible for the impaired motor function. The results are also consistent with the toxicity of Fus/Caz observed in other tissues (Additional file 1: Table S1).
To further elucidate whether Fus overexpression caused any defects in motor neuron cell bodies, we next examined the motor neurons in larval ventral nerve cord (VNC) from late third instar larvae expressing different Fus/Caz proteins by the OK371-Gal4. Motor neurons in the ventral clusters are well-organized in the larval VNC in wild-type flies (Figure 5A). In addition, longitudinal motor neurons, which ensheath the cortex of the VNC, are logitudinally connected, and the segmental nerve of the abdominal neuromeres A1-A5 are well-organized in wild-type flies (Figure 5B). As expected, we found that the OK371-Gal4-mediated expression of Fus, FusR521G, or Caz induced disorganized motor neurons in A1-A5 of the larval VNC (Figure 5C, D, and F). In contrast, the overexpression of FusΔ32 again had no effect on the organization of neuromeres A1-A5 (Figure 5E), which was consistent with the finding that this truncation mutant had no toxicity in motor neurons (Figures 3 and 4).
To solidify the relationship between nuclear localization and toxicity, we constructed Myc-tagged FusNES with a typical nuclear export signal (NES) fused in frame to the C-terminus of FUS (Myc-FusNES) and Myc-tagged chimeric FusΔ32NLS with the NLS of another RNA binding protein hnRNP D fused to the C-terminus of FusΔ32 (Myc-FusΔ32NLS). We then generated transgenic lines at the 75B1 - VK5 attP locus. Expression of FusNES by the OK371-Gal4 had markedly less effect in larva VNC (Figure 5G) and did not induce locomotive defects in the third instar larvae (Figure 5I). Thus, both FusΔ32 and FusNES were largely non-toxic in a similar fashion. In contrast, expression of FusΔ32NLS induced disorganization of motor neurons in VNC (Figure 5H) and caused locomotive defects at a comparable level as in flies expressing Fus (Figure 5I). We also found that FusNES did not cause any phenotype in the eyes or NMJs when driven by GMR-Gal4 or OK371-Gal4, whereas FusΔ32NLS did (Table S1).
We examined the subcellular localization of Fus/Caz proteins using confocal microscopy. Consistent with our previous findings in mammalian cells , we found that Fus, Caz, and FusΔ32NLS were largely localized in the nuclei of motor neurons in the VNC (Additional file 1: Figures S2A and S2D). There was a small increase in cytoplasmic staining of FusR521G (Additional file 1: Figure S2B), whereas FusΔ32 and FusNES were largely cytosolic (Additional file 1: Figure S2C and S2E). Taken together, the data from all tissues examined (Figures 1, 2, 3, 4) suggest that the toxicity of Fus/Caz in flies is likely due to, at least in part, the abnormal function caused by the nuclear fraction of Fus/Caz protein.
The expression of Fus/Caz induces apoptosis in motor neurons
In the above experiment, we observed an abnormal nuclear structure in motor neurons overexpressing Fus/Caz when the cells were stained with Hoechst 33342 nuclear dye. Motor neuron cells expressing the mGFP alone showed a normal even nuclear staining (arrow in Figure 6A), which was almost identical to the structure of the adjacent non-motor neuronal cells (arrowhead in Figure 6A). Surprisingly, the overexpression of Fus or Caz with mGFP resulted in decreased nuclear staining reminiscent of apoptotic bodies in the GFP-positive motor neurons (arrows in Figure 6B and 6E). In contrast, the nuclear staining was largely uniform in the adjacent non-Fus/Caz-expressing cells (arrowheads in Figure 6B and 6E). Consistent with the earlier data, the expression of FusR521G gave rise to a similar effect to that of Fus (arrow in Figure 6C). The expression of FusΔ32 and FusNES gave rise to normal nuclear staining in motor neurons (arrows in Figures 6D and 6E), whereas FusΔ32NLS induced abnormal nuclear staining (arrow in Figure 6G). These data again suggest that the toxicity of Fus/Caz is caused, at least in part, by the protein localized in the nucleus.
We next performed the terminal deoxynucleotodyl transferase dUTP nick end labeling (TUNEL) assay to examine whether the expression of Fus/Caz could induce apoptosis in the VNC. We did not detect any TUNEL-positive cells in control third instar larval VNC (Figure 6H). However, Fus expression in VNCs led to approximately 20-30 TUNEL-positive cells in the same larval stage (Figure 6I), suggesting that overexpression of Fus induced neuronal apoptosis in the VNC. In contrast, the overexpression of FusΔ32 or FusNES did not give rise to TUNEL-positive cells (Figure 6J, not shown), which was consistent with the finding that FusΔ32 and FusNES induced little disorganization of motor neurons in the VNC. In addition, we found that the overexpression of Caz induced approximately 40-50 TUNEL-positive cells in the VNC (Figure 6K), which could explain why the overexpression of Caz at an equivalent level as Fus led to a more severe toxicity. Our results suggest that the neurodegeneration induced by Fus/Caz overexpression occurs due to apoptosis in the Drosophila VNC.
The phenotypes of caz deletion mutant Drosophila
Our initial study of caz inactivation in flies using the RNAi lines from the Vienna Drosophila RNAi Center (VDRC) found that CazRNAi caused a defective morphology in the wing (Figure 1F) and reduced the viability of adult flies (Figure 1G-H). Next, we explored the neuronal function of Caz by analyzing caz mutant phenotypes. A deficiency line DF(1)BSC759, which harbors a deletion in caz and other genes upstream of caz, was first used. DF(1)BSC759 heterozygous females exhibited wild-type eyes with the balancer marker (Figure 7B), but DF(1)BSC759 homozygous females were lethal at the pupa stage and the adult escapers exhibited loss of ommatidia in the eyes (Figure 7C and Additional file 1: Figure S3C). DF(1)BSC759 males also showed a similar eye phenotype (Figure 7E and Additional file 1: Figure S3E). These data suggest that the lack of Caz disrupts the formation of Drosophila ommatidia. Another deficiency line DF(1)ED7355, which retains the wild-type caz gene but lacks a fragment upstream of caz, was able to suppress the eye phenotypes in the complementary test. The results suggest that the phenotype in DF(1)BSC759 was caused by the loss of caz but not other genes. We also examined the other caz mutant allele caz1  and found that caz1 mutant had similar phenotypes as DF(1)BSC759.
We next examined how caz deletion caused the degenerative phenotypes in eyes as seen in the caz homozygous flies (Figure 7C', compared to Figures 7A' and 7B'). An anti-HRP antibody was used to detect the photoreceptor neurons and an anti-Elav antibody to detect the pan neurons in third instar larvae. The Elav signal was evenly distributed in the well-organized ommatidia units of eye discs in the wild-type (Figure 7F-F') and caz heterozygous female (Figure 7G-G') flies. In contrast, the eye discs from caz/caz homozygous female (Figure 7H-H') and caz/y male (Figure 7I-I') flies showed a substantially decreased Elav staining with abnormal puncta in disorganized ommatidia. In addition, Caz knockdown by RNAi also disrupted ommatidia formation (Figure 7Q). These data suggest that Caz is required for maintaining normal function of the neurons in the eye.
We next assessed the function of Caz in Drosophila motor neurons. Loss of caz in motor neurons significantly impaired the locomotive ability of adult flies of both males and females (Figure 7J) and shortened the lifespan of adult flies (data not shown). Male caz mutant larvae showed severe reduction in locomotive activity (Figure 7K). Examination of the NMJs in the male mutant larvae revealed a severe decrease in numbers for both big and small boutons in the NMJs (Figure 7L-M). The eye phenotype was fully rescued by expressing wild-type Fus or Caz (data not shown), which is consistent with the findings in fly locomotive function rescue from a previous study . These results suggest that Caz is required for the function of photoreceptor neurons as well as motor neurons.
We further assessed the organization of the motor neurons in VNC in caz mutant flies as we did in the Fus/Caz overexpressing flies. We found that caz mutant male flies exhibited disorganized motor neurons in neuromeres A1-A5 of the VNC (Figure 7N), a phenotype similar to that caused by the overexpression of Fus/Caz (Figure 5C and 5F). However, unlike the Fus/Caz overexpression flies, loss of caz did not cause any decrease in nuclear staining by Hoechst 33342 (arrow in Figure 7O). Mutating caz in the motor neurons also did not produce any TUNEL-positive cells in the VNC (Figure 7P). These results suggest that the loss of caz did not promote cell death of motor neurons although it disrupted NMJs and impaired locomotive function in the caz mutant flies. Consistent with these results, Caz RNAi also interrupted the arrangement of motor neurons in VNCs (Figure 7R), but did not cause any decrease in nuclear staining (Additional file 1: Figure S7) or any TUNEL-positive cells (not shown). Collectively, these data suggest that the mechanism underlying the phenotypes in the caz mutant line is different from that in the Fus/Caz overexpression flies.
The vast majority of the molecules critical to neuronal function are conserved between Drosophila and more complex vertebrate systems, thus Drosophila is a powerful model to study neurodegenerative diseases including ALS. In this study, we showed that the overexpression of human Fus as well as the Drosophila homolog Caz caused neuronal toxicity in vivo in all Gal4 lines that we tested, including ubiquitous expression (act5C-Gal4), wings (MS1096-Gal4), eyes (GMR-Gal4), neurons (Elav-Gal4) and motor neurons (D42- and OK371-Gal4). Since Fus/Caz protein was expressed at late larval or pupal stages and the degenerative phenotypes were progressive with aging, the Fus/Caz overexpressing flies are a reasonably good model to study the relevance of Fus in motor neuron degeneration in ALS. Furthermore, we provide evidence that both loss of Caz and overexpression of Fus/Caz can induce phenotypic defects although the underlying cellular mechanisms are likely to be different in these two models.
Nuclear toxicity of Fus/Caz in the absence of cytoplasmic inclusions
It has been recently shown that the overexpression of Fus in flies leads to neuronal toxicity [25–27]. However, it is unknown whether overexpression of Drosophila Caz can cause toxicity. In this study, overexpression of fly Caz caused similar or even more severe toxicity in all experiments compared to overexpression of human Fus (Figures 1, 2, 3, 4). This is reminiscent of the studies of another ALS-implicated RNA binding protein TDP-43 that the overexpression of TDP-43 was shown to be toxic in yeast , Drosophila [23, 24, 34, 35], C. elegans , and mouse [37, 38]. It is noted that protein inclusions of wild-type Fus have also been reported in human ALS patients [7, 8]. These findings underscore the importance of understanding the underlying molecular mechanisms of Fus in ALS.
Our group and others have shown that the last 32 amino acids of the protein contain an NLS that is both essential and sufficient for nuclear targeting. It has also been shown that the ALS-related mutations in Fus increased the cytoplasmic localization of the protein and promoted the co-localization of Fus with stress granules in the cytosol [19–21]. However, the cytoplasmic accumulation may not be essential or sufficient for the toxicity observed for the protein [39, 40]. Thus, the link between toxicity and subcellular localization of Fus needs to be characterized in vivo.
A novel finding of this study is that Fus nuclear localization is required for its toxicity in Drosophila. The overexpression of FusΔ32 at comparable levels consistently showed little or no toxicity in all tissues. The in vivo subcellular localization of wild-type Fus, R521G mutant and FusΔ32 was confirmed to be consistent with the findings in cell culture, i.e. FusΔ32 was largely diffused outside of the nucleus. Moreover, the fusion of an NES at the C-terminus of the full-length wild-type Fus dramatically reduced toxicity in vivo (Figures 5G, I and 6F). FusNES was also diffused in the motor neurons (Additional file 1: Figure S2), thus the data from both FusNES and FusΔ32 suggest that the nuclear localization is critical to the toxicity. Furthermore, the chimeric protein FusΔ32NLS with an exogenous NLS was localized in the nucleus (Additional file 1: Figure S2) and produced similar toxicity as wild-type Fus (Figure 5H, I, and 6G). All these results consistently suggest that the nuclear localization is required for Fus toxicity.
This surprising result differs from the common presumption that the toxicity is caused by the cytoplasmic accumulation of Fus. Our study is the first one characterizing transgenic flies expressing truncated Fus mutant with a primarily cytoplasmic localization. We further manipulated the subcellular localization by using a typical NES and the other different NLS. All experiments consistently support the conclusion. Interestingly, another study showed that mutation in the NLS of TDP-43 relieved the toxicity in C. elegans , supporting the conclusion of our study. However, the study by Lanson et al. employed another approach by deleting a postulated NES within the RNA recognition motif of Fus and showed reduced toxicity . It should be noted that Lanson et al. did not characterize the NES or the subcellular localization of the NES deletion mutant. Moreover, the postulated NES is within the RNA binding domain in Fus, therefore such deletion may cause a disruption of the RNA binding properties of Fus. Thus, the mechanism of the reduced toxicity of that particular NES deletion mutant needs to be better elucidated. We are confident in our conclusion since the results using three different approaches (FusΔ32, FusNES, and FusΔ32NLS) consistently support the requirement of nuclear localization for Fus toxicity.
Another critical difference between this study and the study by Lanson et al. is how the transgenic flies were generated. The site-specific transgenic approach using the integrase-mediated insertion at the specific attP locus allowed us to ensure equal expression of the Fus proteins without positional effects. We think that the discrepancy is likely due to the expression level of the protein. This likely explains the discrepancy regarding the toxicity of the Fus transgene in different studies. The R521G mutation produced comparable levels of toxicity as wild-type Fus whereas the other study showed more severe toxicity in flies expressing R521H or R521C . The experiments in our study are more likely to produce comparable expression levels of the Fus transgene since transgene insertion was random in other studies.
Disruption of muscle 6/7 NMJs was observed in the Fus transgenic flies in this study. It is important to note that NMJ vulnerability occurs selectively in different subgroups of motor neurons or muscles. The diversity of subtypes of motor neurons and muscles and their susceptibility are well documented in ALS . We examined the muscle 6/7 NMJs in the abdominal segment A2 of the third instar larvae, which is widely used in Drosophila studies. In addition, we used GFP as a marker to monitor the target protein expression. Our results showed the expression of Fus/Caz in the disrupted NMJs. Studies characterizing NMJs in other muscles may obtain different results, for example another study examined muscle 4, segment A2 and 3 and did not observe reduction of synaptic boutons in Fus overexpressing flies .
Notably, neither wild-type Fus/Caz nor the ALS mutants of Fus showed cytoplasmic inclusions in transgenic flies where severe toxicity was demonstrated in this study. The results suggest that the cytoplasmic inclusions are not essential to Fus toxicity although they have been prominently observed in cell culture systems and in human patient tissues. It has long been proposed that soluble oligomers may be the culprit species causing neurodegenerative disease. A recent study showed that aberrant high molecular weight complex of TDP-43 was toxic, although the nature of the species was still unknown . A recent study also showed that Fus toxicity could be suppressed without eliminating protein inclusions in yeast , suggesting that protein inclusions might be a non-toxic and non-essential feature of the disease.
Although the results in this study consistently suggest that sufficient steady-state levels of Fus/Caz are required for the toxicity and neurodegenerative phenotypes, it is noted that Fus/Caz undergoes dynamic trafficking in and out of the nucleus in live cells. It remains possible that Fus/Caz with steady-state nuclear localization could produce detrimental effect while it is temporarily outside of the nucleus. Alternatively, the minute amount of Fus/Caz in the cytoplasm that cannot be detected by confocal microscope could also produce cytosolic toxicity. We believe that these two are remote possibilities, however additional studies using more sophisticated approaches are needed to test them in the future. Moreover, the exact nature of Fus toxicity in the nucleus also remains to be determined in future studies.
The phenotypes of caz deletion in Drosophila
Deletion of a specific gene provides insight into understanding the in vivo function of the protein. By taking advantage of the Drosophila model, we found that endogenous Caz is required for normal functions of the neurons (Figure 7). The deficiency of caz in flies induced a strong eye phenotype with disrupted ommatidia structure (Figure 7A-I) and caused defects in the locomotive function in larvae (Figure 7K) and adult flies (Figure 7J). Consistently, caz1 mutant flies exhibited decreased adult viability and diminished locomotive activity . These phenotypes were actually similar to those caused by Fus/Caz overexpression. It would be interesting to examine whether some cases of ALS disease may be caused by Fus loss-of-function in patients.
Given the motor deficiencies of Fus overexpression and mutant caz flies, the presynaptic structure in NMJ was examined. As expected, the number of boutons was significantly reduced in the larvae overexpressing Fus (Figure 4) as well as in the larvae lacking caz (Figure 7L-M). Thus the disruption of NMJ was evidently the cause of the locomotive defects. Therefore, the Fus/Caz overexpression and loss of caz obviously caused similar disruption of presynaptic terminals in NMJs. It is likely that Caz is required for neuronal function and therefore the lack of Fus/Caz perturbs the motor neuron distal terminus and causes NMJ disruption.
Different molecular mechanisms for degenerative phenotypes in Fus overexpression and caz deletion Drosophila
By examining the nuclear structure and monitoring apoptosis of cells in the VNC, we found that overexpression of Fus/Caz induced apoptotic cell death (Figure 6). However, neither the caz deficiency (BSC759) nor the caz1 mutation led to apoptosis (Figure 7P and 7S, data not shown). Despite the critical difference, both Fus/Caz overexpression and caz deletion disrupted the NMJs. This raises the question of where the toxicity originates, either from the death of neuronal cell bodies or disruption of the NMJs.
Studies in the SOD1 mutant-mediated familial ALS have suggested an axon die-back model in which perturbation at the distal NMJs occurs prior to the death of motor neurons . The Fus/Caz overexpression phenotypes support this model, but the time sequence of the NMJ disruption and motor neuron death has not been distinguished in these flies as yet. Moreover, both the caz deficiency and caz1 mutant flies strongly support this model since loss of Fus/Caz caused NMJ disruption and motor function deficiency without the presence of motor neuronal cell death. The findings in our study support two potential mechanisms for the Fus/Caz mediated neurotoxicity: neuronal apoptosis and NMJ perturbation. These two mechanisms are not necessarily mutually exclusive, and in fact may occur simultaneously. Further studies exploring of the in-depth mechanisms by which Fus/Caz causes alterations in RNA processing and nuclear toxicity are currently ongoing. Many laboratories in the field also use various models, including yeast [39, 40, 43, 44] and Drosophila [25–27], to investigate the role of Fus in RNA metabolism and the genetic interactions between Fus and other RNA processing proteins. The overexpression and deletion Drosophila models in this study provide valuable insight into the etiology of ALS and potentially other degenerative diseases in which RNA processing proteins are implicated.
We conclude from our study that the expression of Fus can cause nuclear toxicity, induce apoptosis and facilitate NMJ perturbation in the transgenic Drosophila model of ALS. Generation and characterization of the Drosophila model of Fus-mediated ALS have revealed several novel findings and provided new insights into the disease etiology. There are three major novel findings in this study: (1) the C-terminus of Fus is essential for its in vivo toxicity, suggesting that Fus toxicity originates from the nuclei instead of the cytoplasm; (2) both the overexpression of Fus/Caz and the deletion of caz caused similar deficiency in locomotive function and disruption in NMJs; (3) the overexpression of Fus/Caz induced apoptosis in motor neuron cell bodies, whereas no apoptosis was observed in the motor neurons of the caz mutant flies. In addition to the novel findings, we have also developed assays to investigate the functions of Fus/Caz in the Drosophila VNC. The novel neuronal functions of Caz that we have uncovered here are likely to be conserved in other species.
Constructs, mutants, and transgenes
UAST-Myc-Fus was generated by subcloning the cDNA fragment of human Fus into the attB-UAST-5xMyc vector. Amino acid substitutions of R521G, R521C, and Y526F were generated by PCR-based site-directed mutagenesis. FusΔ32 and Fus1-453 were generated by truncation at F494 and G453, respectively. FusR521G, FusR521C, FusY526F, Fus1-453, and FusΔ32 were subcloned into attB-UAST-5xMyc using the same approach as used for Fus. To generate FusNES, the typical NES sequence (NINELALKFAGLDI)  was fused in frame with the C-terminus of Myc-Fus. To generate FusΔ32NLS, the NLS sequence (YGDYSNQQSGYGKVSRRGGHQNSYKPY) from hnRNP D  was fused in frame with FusΔ32. To generate HA-tagged Caz (HA-Caz), we obtained cDNA clone (LD22761) from the Drosophila Genome Resource Center (DGRC, USA) and subcloned the full-length Caz cDNA into attB-UAST-HA vector. To ensure that the proteins were expressed at the same level without a positional effect, the PhiC31 integration system was used to integrate Fus and Caz transgenes into the 75B1 attP locus in the fly genome [30, 31]. The Caz RNAi line, v100291, and the UAS-Dicer lines were obtained from the VDRC (Austria). DF(1)BSC759 and DF(1)ED7355 were obtained from the Bloomington Drosophila Stock Center (USA). caz1 mutant flies carry deletion Df383 and a genomic transgene for CG32576, which is supposed to be a caz null . MS1096-Gal4; D42-Gal4, Elav-Gal4, act5C-Gal4, GMR-Gal4, OK371-Gal4, UAS-Dicer, and yw have been previously described (Flybase) .
Adult eye histology, immunoblot analysis, and eye imaginal disc immunostaining
To analyze the internal structure of adult eyes, the heads of flies from specific genotypes at 4 day-after-eclosion (DAE) were fixed in Bouin's fixative solution (Cat# HT10132, Sigma, USA) for 48 h at room temperature on a shaker at low speed, incubated 24 h in 50 mM Tris/150 mM NaCl, and then embedded in paraffin. Serial sections (5 μm thickness) were taken through the entire head, stained with Eosin (Cat# S176, Poly Scientific, USA), and examined under a Leica DM750 microscope (Leica, Germany). Western blot was performed to confirm comparable levels of protein expression. Fifteen heads from adults expressing different Fus or Caz transgenes by GMR-Gal4 were dissected and subjected to direct Western blot with mouse anti-Myc (9E10, 1:5000, Santa Cruz, USA) and anti-β-tubulin (1:5000, Developmental Studies Hybridoma Bank; DSHB, USA). A standard protocol was used for the eye imaginal disc immunostaining assay. Eye discs were dissected, fixed in 4% paraformaldehyde, washed in phosphate-buffered saline with 0.3% Triton-X100 (PBT), and then stained with mouse anti-Elav (1:50, DSHB) for 2 h at room temperature. After washing with PBT, the eye discs were stained with goat anti-mouse Rhodamin (1:500, Jackson ImmunoResearch, USA) and rabbit anti-Horseradish Peroxidase (HRP) conjugated to Cy5 (1:500, Jackson ImmunoResearch) for 2 hours at room temperature.
Dissection, immunostaining, and analysis of NMJs from third instar larvae
Late third instar larvae were dissected, fixed in 4% paraformaldehyde, washed in PBT, and stained with an anti-Discs-large (Dlg) antibody (1:100, DSHB) at room temperature for 2 h. After washing with PBT, the discs were stained with goat anti-mouse Rhodamin (1:500, Jackson ImmunoResearch) and rabbit anti-HRP antibody conjugated to Cy5 (Jackson ImmunoResearch, 1:500). Samples were then mounted and viewed with an Olympus confocal microscope. Z-scan sections of the NMJs from ventral longitudinal muscles 6 and 7 at segment A2 were taken at 1.0 μm intervals by confocal imaging (Olympus Fluoview, Ver.1.7c) to visualize the HRP-positive neuronal membrane and the Dlg-positive large boutons. The number of large and small boutons was also quantified after intensity projection over the Z axis.
Immunostaining and TUNEL assay of the VNCs from third instar larvae
Fly larval VNCs with brains from specific genotypes were dissected, fixed in 4% paraformaldehyde, and immunostained with mouse anti-Myc (9E10, 1:50, Santa Cruz) or anti-HA (F-7, 1:150, Santa Cruz) for 2 h at room temperature. After washing with PBT, the tissues were stained with goat anti-mouse Rhodamin (1:500, Jackson ImmunoResearch). Hoechst dye 33342 (1 μg/ml, Invitrogen, USA) was added with the secondary antibody staining. For TUNEL staining, samples were pretreated with 3 μg/ml Proteinase K for 10 min at room temperature, fixed in 4% paraformaldehyde, and permeabilized in PBT with 0.1% sodium citrate. Samples were then treated with TUNEL (In Situ Cell Death Detection Kit) with green fluorescence (Roche, Cat# 11684795910) followed by imaging analysis with the Olympus confocal microscope.
Western blot was performed to confirm protein expression at a comparable level. Five brains containing VNCs from larvae expressing Fus variants or Caz by OK371-Gal4 were dissected and lysed in regular Schneider S2 cell lysis buffer, and then subjected to direct Western blot with mouse anti-Myc (9E10, 1:5000, Santa Cruz), anti-HA (F-7, 1:1500, Santa Cruz), or anti-GFP (1:1000, Millipore, USA).
Larval movement and adult climbing assays
Third instar larvae bearing specific genotypes were subjected to motor function analysis on 100 mm agar plates. Individual larvae were placed on plates and stimulated to move with a needle. The distance they traveled over the next 30 s was traced and measured. Each individual larva was counted 3 times and 20 larvae were tested for each group. The climbing ability of adult flies with different genotypes was examined in empty 2 ml pipettes vertically. Flies were first placed at the bottom of the pipette and the climbing distances were scored over 30 s. Each fly was recorded 3 times and 20 flies in each group were tested.
Amyotrophic lateral sclerosis
Fused in sarcoma
Ventral nerve cord
Nuclear localization sequence
Nuclear export signal
Cu/Zn superoxide dismutase
Boillee S, Vande Velde C, Cleveland DW: ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron. 2006, 52 (1): 39-59. 10.1016/j.neuron.2006.09.018.
Valdmanis PN, Rouleau GA: Genetics of familial amyotrophic lateral sclerosis. Neurology. 2008, 70 (2): 144-152.
Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993, 362 (6415): 59-62. 10.1038/362059a0.
Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, et al: TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008, 319 (5870): 1668-1672. 10.1126/science.1154584.
Sapp PC, Hosler BA, McKenna-Yasek D, Chin W, Gann A, Genise H, Gorenstein J, Huang M, Sailer W, Scheffler M, et al: Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet. 2003, 73 (2): 397-403. 10.1086/377158.
Ruddy DM, Parton MJ, Al-Chalabi A, Lewis CM, Vance C, Smith BN, Leigh PN, Powell JF, Siddique T, Meyjes EP, et al: Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Hum Genet. 2003, 73 (2): 390-396. 10.1086/377157.
Kwiatkowski TJ, Bosco DA, LeClerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al: Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009, 323 (5918): 1205-1208. 10.1126/science.1166066.
Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al: Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009, 323 (5918): 1208-1211. 10.1126/science.1165942.
Belzil VV, Valdmanis PN, Dion PA, Daoud H, Kabashi E, Noreau A, Gauthier J, Hince P, Desjarlais A, Bouchard JP, et al: Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology. 2009, 73 (15): 1176-1179. 10.1212/WNL.0b013e3181bbfeef.
Corrado L, Del Bo R, Castellotti B, Ratti A, Cereda C, Penco S, Soraru G, Carlomagno Y, Ghezzi S, Pensato V, et al: Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet. 2010, 47 (3): 190-194. 10.1136/jmg.2009.071027.
DeJesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, Johnston A, Rutherford N, Wojtas A, Kennelly K, et al: De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum Mutat. 2010, 31 (5): E1377-E1389. 10.1002/humu.21241.
Bertolotti A, Lutz Y, Heard DJ, Chambon P, Tora L: hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 1996, 15 (18): 5022-5031.
Zinszner H, Sok J, Immanuel D, Yin Y, Ron D: TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci. 1997, 110 (Pt 15): 1741-1750.
Lagier-Tourenne C, Polymenidou M, Cleveland DW: TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet. 2010, 19 (R1): R46-R64. 10.1093/hmg/ddq137.
Fujii R, Okabe S, Urushido T, Inoue K, Yoshimura A, Tachibana T, Nishikawa T, Hicks GG, Takumi T: The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol. 2005, 15 (6): 587-593. 10.1016/j.cub.2005.01.058.
Fujii R, Takumi T: TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J Cell Sci. 2005, 118 (Pt 24): 5755-5765.
Andersson MK, Stahlberg A, Arvidsson Y, Olofsson A, Semb H, Stenman G, Nilsson O, Aman P: The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol. 2008, 9: 37-10.1186/1471-2121-9-37.
Aman P, Panagopoulos I, Lassen C, Fioretos T, Mencinger M, Toresson H, Hoglund M, Forster A, Rabbitts TH, Ron D, et al: Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics. 1996, 37 (1): 1-8. 10.1006/geno.1996.0513.
Gal J, Zhang J, Kwinter DM, Zhai J, Jia H, Jia J, Zhu H: Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging. 2011, 32 (12): 2323-e27-40
Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, et al: ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010, 29 (16): 2841-2857. 10.1038/emboj.2010.143.
Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ, Sapp P, McKenna-Yasek D, Brown RH, Hayward LJ: Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet. 2010, 19 (21): 4160-4175. 10.1093/hmg/ddq335.
Feiguin F, Godena VK, Romano G, D'Ambrogio A, Klima R, Baralle FE: Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009, 583 (10): 1586-1592. 10.1016/j.febslet.2009.04.019.
Li Y, Ray P, Rao EJ, Shi C, Guo W, Chen X, Woodruff EA, Fushimi K, Wu JY: A Drosophila model for TDP-43 proteinopathy. Proc Nat Acad Sci USA. 2010, 107 (7): 3169-3174. 10.1073/pnas.0913602107.
Ritson GP, Custer SK, Freibaum BD, Guinto JB, Geffel D, Moore J, Tang W, Winton MJ, Neumann M, Trojanowski JQ, et al: TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci. 2010, 30 (22): 7729-7739. 10.1523/JNEUROSCI.5894-09.2010.
Lanson NA, Maltare A, King H, Smith R, Kim JH, Taylor JP, Lloyd TE, Pandey UB: A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43. Hum Mol Genet. 2011, 20 (13): 2510-2523. 10.1093/hmg/ddr150.
Chen Y, Yang M, Deng J, Chen X, Ye Y, Zhu L, Liu J, Ye H, Shen Y, Li Y, et al: Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell. 2011, 2 (6): 477-486. 10.1007/s13238-011-1065-7.
Wang JW, Brent JR, Tomlinson A, Shneider NA, McCabe BD: The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J Clin Invest. 2011, 121 (10): 4118-26. 10.1172/JCI57883.
Immanuel D, Zinszner H, Ron D: Association of SARFH (sarcoma-associated RNA-binding fly homolog) with regions of chromatin transcribed by RNA polymerase II. Mol Cell Biol. 1995, 15 (8): 4562-4571.
Stolow DT, Haynes SR: Cabeza, a Drosophila gene encoding a novel RNA binding protein, shares homology with EWS and TLS, two genes involved in human sarcoma formation. Nucleic Acids Res. 1995, 23 (5): 835-843. 10.1093/nar/23.5.835.
Bischof J, Maeda RK, Hediger M, Karch F, Basler K: An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Nat Acad Sci USA. 2007, 104 (9): 3312-3317. 10.1073/pnas.0611511104.
Jia H, Liu Y, Xia R, Tong C, Yue T, Jiang J, Jia J: Casein kinase 2 promotes Hedgehog signaling by regulating both smoothened and Cubitus interruptus. J Biol Chem. 2010, 285 (48): 37218-37226. 10.1074/jbc.M110.174565.
Bilen J, Bonini NM: Drosophila as a model for human neurodegenerative disease. Annu Rev Genet. 2005, 39: 153-171. 10.1146/annurev.genet.39.110304.095804.
Johnson BS, McCaffery JM, Lindquist S, Gitler AD: A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Nat Acad Sci USA. 2008, 105 (17): 6439-6444. 10.1073/pnas.0802082105.
Hanson KA, Kim SH, Wassarman DA, Tibbetts RS: Ubiquilin modifies TDP-43 toxicity in a Drosophila model of amyotrophic lateral sclerosis (ALS). J Biol Chem. 2010, 285 (15): 11068-11072. 10.1074/jbc.C109.078527.
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, et al: Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010, 466 (7310): 1069-1075. 10.1038/nature09320.
Ash PE, Zhang YJ, Roberts CM, Saldi T, Hutter H, Buratti E, Petrucelli L, Link CD: Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum Mol Genet. 2010, 19 (16): 3206-3218. 10.1093/hmg/ddq230.
Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH: TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci. 2009, 106 (44): 18809-18814. 10.1073/pnas.0908767106.
Igaz LM, Kwong LK, Lee EB, Chen-Plotkin A, Swanson E, Unger T, Malunda J, Xu Y, Winton MJ, Trojanowski JQ, Lee VMY: Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest. 2011, 121 (2): 726-738. 10.1172/JCI44867.
Sun Z, Diaz Z, Fang X, Hart MP, Chesi A, Shorter J, Gitler AD: Molecular Determinants and Genetic Modifiers of Aggregation and Toxicity for the ALS Disease Protein FUS/TLS. PLoS Biol. 2011, 9 (4): e1000614-10.1371/journal.pbio.1000614.
Ju S, Tardiff DF, Han H, Divya K, Zhong Q, Maquat LE, Bosco DA, Hayward LJ, Brown RH, Lindquist S, et al: A Yeast Model of FUS/TLS-Dependent Cytotoxicity. PLoS Biol. 2011, 9 (4): e1001052-10.1371/journal.pbio.1001052.
Kanning KC, Kaplan A, Henderson CE: Motor neuron diversity in development and disease. Annu Rev Neurosci. 2010, 33: 409-440. 10.1146/annurev.neuro.051508.135722.
Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, Rao EJ, Yang M, Ye H, Zhu L, et al: An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol. 2011, 18 (7): 822-830. 10.1038/nsmb.2053.
Fushimi K, Long C, Jayaram N, Chen X, Li L, Wu JY: Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell. 2011, 2 (2): 141-149. 10.1007/s13238-011-1014-5.
Kryndushkin D, Wickner RB, Shewmaker F: FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis. Protein Cell. 2011, 2 (3): 223-236. 10.1007/s13238-011-1525-0.
Guttler T, Madl T, Neumann P, Deichsel D, Corsini L, Monecke T, Ficner R, Sattler M, Gorlich D: NES consensus redefined by structures of PKI-type and Rev-type nuclear export signals bound to CRM1. Nat Struct Mol Biol. 2010, 17 (11): 1367-1376. 10.1038/nsmb.1931.
Lee BJ, Cansizoglu AE, Suel KE, Louis TH, Zhang Z, Chook YM: Rules for nuclear localization sequence recognition by karyopherin beta 2. Cell. 2006, 126 (3): 543-558. 10.1016/j.cell.2006.05.049.
We thank Mary K. Brewer for technical assistance, and Drs. Hongge Jia and Jiayu Zhang for making some of the Fus/Caz constructs. We thank the Bonini Lab for providing a detailed protocol of the fly eye paraffin section. We thank Dr. Brian McCabe for the caz1 mutant. We thank the Developmental Studies Hybridoma Bank (DSHB) for antibodies and the Bloomington Stock Center for Drosophila strains. This work was in part supported by the National Institutes of Health grants (R01NS077284, R01NS049126 and R21AG032567 to HZ), the ALS Association (6SE340 to HZ), and the Center of Biomedical Research Excellence in the Molecular Basis of Human Disease (COBRE, P20RR020171).
The authors declare that they have no competing interests.
RX, YL, LY, JG performed the experiments. HZ and JJ analyzed the results, designed the study, and wrote the manuscript. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 1: Figure S1 The caz gene encodes the Drosophila homolog of Fus. A sequence alignment between Caz, mouse Fus, and human Fus is shown here. The SYQG domain, G-rich domain, RNA binding domain, Zn-finger domain, and RGG-rich domains are underlined. The asterisks indicate the ALS-related mutations that occur in patients. Additional file 1: Figure S2 Large magnification of the motor neuronal cells indicating the localization of the proteins expressed in VNCs from Figure 5. Fus, Caz, and FusΔ32NLS are exclusively localized in the nucleus. FusR521G shows slightly increased staining in the cytosol, but FusΔ32 and FusNES are mainly localized in the cytoplasm. Additional file 1: Figure S3 Mutating caz in flies causes severe defects in the eye. (A) A female yw fly showing adult wild-type morphology. (B) A caz heterozygous female fly shows the balancer marker and intact eye structure. (C) A caz homozygous female fly shows growth defects in the eye and exhibits a normal body. (D) A male yw fly showing adult wild-type morphology. (E) A caz mutant male fly shows growth defects in the eye and exhibits a normal body. Mutating caz causes severely disrupted locomotive ability (Figure 7) without obvious changes in body size, suggesting that Caz is likely involved in neurodegeneration. Additional file 1: Table S1 Characterization of Fus toxicity in Drosophila. Shown here is a diagram illustrating the domain structure of Fus along with truncation and point mutation constructs that are expressed in flies by the indicated Gal4 lines. The levels of toxicity are determined in the wing (by MS1096-Gal4), the eye (by GMRGal4), the entire body (by the act5C-Gal4), and the neuron (by Elav-Gal4 and D42-Gal4). More "+" symbols indicates more severe phenotypes. (PDF 977 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.